Copenhagen | Denmark
| Investor Type | Firm |
| Industries | BioTech • FinTech (& Financials services) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Healthcare (& Wellness) • LegalTech • Pharmaceutical (& Medicine) |
| Stages | Acquisition, Seed, Series A, Series B, Pre-seed |
| Investing | United States • United Kingdom • France • Spain • Sweden • Switzerland • Denmark • Europe • Norway |
| Investment Range | $100,000 - $5,000,000 |
| Investment Sweet Spot | $1,500,000 |
About The Fund
Ventac Partners is an investment firm that specializes in life science consulting and building biotechnology companies. It is headquartered in Boston, Massachusetts, and has been operational since 2002. Ventac Partners offers a range of services that cater to the needs of life science companies at various stages of development. These services include technology transfer, licensing, mergers and acquisitions, fundraising, investor relations, preclinical, clinical and regulatory issues, and patent portfolio development and management. Their investment focus lies in a diverse array of industries within the life sciences sector including BioTech, FinTech and Financial Services, HealthTech and Fitness, Medical Devices and Hospital Services, Healthcare and Wellness, LegalTech, and Pharmaceuticals and Medicine. With offices spread across Europe, Asia, and the USA, Ventac Partners takes a global approach to investment and consultative activities. They engage in Acquisition, Seed, Series A, Series B, and Pre-seed funding stages, with their investment amounts ranging from a minimum of $100,000 to a maximum of $5,000,000, and with a sweet spot of around $1,500,000 for investments. On their website, Ventac Partners highlights their breadth of expertise in company building, financing, IPO arrangements, M&A transactions, and licensing operations. They showcase their ability to act as 'Venture Catalysts in Life Science,' underpinned by a team with extensive entrepreneurial experience dedicated to creating breakthrough companies and fostering scientific innovation for patient benefit worldwide. They also feature a diverse portfolio and keep up with the latest news and events within the space, including grants awarded to portfolio companies, speaking engagements of partners, and educational contributions such as biotech courses.
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
